live attenuated influenza virus
GPTKB entity
Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
intranasal spray
|
| gptkbp:age |
2-49 years
|
| gptkbp:alternativeTo |
gptkb:inactivated_influenza_vaccine
|
| gptkbp:approvedBy |
gptkb:FDA
2003 |
| gptkbp:compatibleWith |
egg allergy (severe)
|
| gptkbp:contains |
live virus
weakened influenza virus |
| gptkbp:contraindication |
pregnant women
immunocompromised individuals |
| gptkbp:developedBy |
gptkb:MedImmune
|
| https://www.w3.org/2000/01/rdf-schema#label |
live attenuated influenza virus
|
| gptkbp:inducedBy |
immune response
|
| gptkbp:notRecommendedFor |
children under 2 years
adults over 49 years |
| gptkbp:requires |
annual administration
|
| gptkbp:routeOfAdministration |
intranasal
|
| gptkbp:sideEffect |
headache
cough sore throat runny nose |
| gptkbp:storage |
refrigerated
|
| gptkbp:target |
gptkb:influenza_B_virus
influenza |
| gptkbp:usedFor |
influenza prevention
|
| gptkbp:usedIn |
gptkb:FluMist
|
| gptkbp:bfsParent |
gptkb:Influenza_vaccine
|
| gptkbp:bfsLayer |
5
|